Patents by Inventor Gary PEH

Gary PEH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enrichment and characterization of human corneal endothelial cells (hCENC) with novel monoclonal antibody
    Patent number: 10287547
    Abstract: This invention refers to an antibody or an antigen binding portion thereof, that binds specifically to human corneal endothelial cells (hCENCs), wherein the target of the monoclonal antibody, or antigen binding portion thereof, is essentially cell surface-expressed Peroxiredoxin-6 (Prdx6), as well as to methods for determining suitability of a cell sample for corneal transplantation, for quantitative enrichment of human corneal endothelial cells from a mixture of cells, and for isolating human corneal endothelial cells from a mixture of cell.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: May 14, 2019
    Assignees: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH, SINGAPORE HEALTH SERVICES PTE LTD
    Inventors: Mei Yee Vanessa Ding, Boon Hwa Andre Choo, Chui Ping Angela Chin, Jodhbir Singh Mehta, Gary Peh
  • Cell culture of corneal endothelial cells
    Patent number: 10017735
    Abstract: The invention relates to a dual-media approach for culturing isolated corneal endothelial cells. Isolated corneal endothelial cells are first contacted with a proliferative medium to propagate and/or expand the endothelial cells followed by a maintenance medium to preserve the morphology and/or characteristics of the corneal endothelial cells. The invention includes the proliferative medium and the maintenance medium and also a combination of the two medium.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: July 10, 2018
    Assignee: SINGAPORE HEALTH SERVICES PTE LTD
    Inventors: Donald Tan, Jodhbir Mehta, Swee Lim Gary Peh
  • ENRICHMENT AND CHARACTERIZATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCENC) WITH NOVEL MONOCLONAL ANTIBODY
    Publication number: 20170037366
    Abstract: This invention refers to an antibody or an antigen binding portion thereof, that binds specifically to human corneal endothelial cells (hCENCs), wherein the target of the monoclonal antibody, or antigen binding portion thereof, is essentially cell surface-expressed Peroxiredoxin-6 (Prdx6), as well as to methods for determining suitability of a cell sample for corneal transplantation, for quantitative enrichment of human corneal endothelial cells from a mixture of cells, and for isolating human corneal en dothelial cells from a mixture of cell.
    Type: Application
    Filed: April 11, 2014
    Publication date: February 9, 2017
    Inventors: Mei Yee Vanessa DING, Boon Hwa Andre CHOO, Chui Ping Angela CHIN, Jodhbir Singh MEHTA, Gary PEH
  • CELL CULTURE OF CORNEAL ENDOTHELIAL CELLS
    Publication number: 20150203815
    Abstract: The invention relates to a dual-media approach for culturing isolated corneal endothelial cells. Isolated corneal endothelial cells are first contacted with a proliferative medium to propagate and/or expand the endothelial cells followed by a maintenance medium to preserve the morphology and/or characteristics of the corneal endothelial cells. The invention includes the proliferative medium and the maintenance medium and also a combination of the two medium.
    Type: Application
    Filed: July 18, 2013
    Publication date: July 23, 2015
    Applicant: SINGAPORE HEALTH SERVICES PTE LTD
    Inventors: Donald Tan, Jodhbir Mehta, Swee Lim Gary Peh